456 related articles for article (PubMed ID: 19940915)
1. Materials engineering for immunomodulation.
Hubbell JA; Thomas SN; Swartz MA
Nature; 2009 Nov; 462(7272):449-60. PubMed ID: 19940915
[TBL] [Abstract][Full Text] [Related]
2. Engineering tolerance using biomaterials to target and control antigen presenting cells.
Tostanoski LH; Gosselin EA; Jewell CM
Discov Med; 2016 May; 21(117):403-10. PubMed ID: 27355336
[TBL] [Abstract][Full Text] [Related]
3. Engineering galectin-glycan interactions for immunotherapy and immunomodulation.
Farhadi SA; Hudalla GA
Exp Biol Med (Maywood); 2016 May; 241(10):1074-83. PubMed ID: 27229902
[TBL] [Abstract][Full Text] [Related]
4. Biomaterials as Local Niches for Immunomodulation.
Adu-Berchie K; Mooney DJ
Acc Chem Res; 2020 Sep; 53(9):1749-1760. PubMed ID: 32786230
[TBL] [Abstract][Full Text] [Related]
5. Biomaterials-based modulation of the immune system.
Gardner AB; Lee SK; Woods EC; Acharya AP
Biomed Res Int; 2013; 2013():732182. PubMed ID: 24171170
[TBL] [Abstract][Full Text] [Related]
6. Immunoengineering has arrived.
Green JJ
J Biomed Mater Res A; 2021 Apr; 109(4):397-403. PubMed ID: 32588490
[TBL] [Abstract][Full Text] [Related]
7. Functional Biomolecule Delivery Systems and Bioengineering in Cartilage Regeneration.
Szychlinska MA; D'Amora U; Ravalli S; Ambrosio L; Di Rosa M; Musumeci G
Curr Pharm Biotechnol; 2019; 20(1):32-46. PubMed ID: 30727886
[TBL] [Abstract][Full Text] [Related]
8. Bioderived polyelectrolyte nanogels for robust antigen loading and vaccine adjuvant effects.
Lim YT; Shim SM; Noh YW; Lee KS; Choi DY; Uyama H; Bae HH; Kim JH; Hong KS; Sung MH; Poo H
Small; 2011 Dec; 7(23):3281-6. PubMed ID: 22009658
[TBL] [Abstract][Full Text] [Related]
9. Dendritic Cells as Targets for Biomaterial-Based Immunomodulation.
Eslami-Kaliji F; Sarafbidabad M; Rajadas J; Mohammadi MR
ACS Biomater Sci Eng; 2020 May; 6(5):2726-2739. PubMed ID: 33463292
[TBL] [Abstract][Full Text] [Related]
10. Modulation of dendritic cell antigen presentation by pathogens, tissue damage and secondary inflammatory signals.
Vega-Ramos J; Roquilly A; Asehnoune K; Villadangos JA
Curr Opin Pharmacol; 2014 Aug; 17():64-70. PubMed ID: 25128781
[TBL] [Abstract][Full Text] [Related]
11. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
Front Immunol; 2018; 9():2874. PubMed ID: 30619259
[TBL] [Abstract][Full Text] [Related]
12. Engineering vaccines and niches for immune modulation.
Purwada A; Roy K; Singh A
Acta Biomater; 2014 Apr; 10(4):1728-40. PubMed ID: 24373907
[TBL] [Abstract][Full Text] [Related]
13. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.
Wang C; Ye Y; Hu Q; Bellotti A; Gu Z
Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28556553
[TBL] [Abstract][Full Text] [Related]
14. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
15. Biomaterial Strategies for Immunomodulation.
Hotaling NA; Tang L; Irvine DJ; Babensee JE
Annu Rev Biomed Eng; 2015; 17():317-49. PubMed ID: 26421896
[TBL] [Abstract][Full Text] [Related]
16. The effect of stable macromolecular complexes of ionic polyphosphazene on HIV Gag antigen and on activation of human dendritic cells and presentation to T-cells.
Palmer CD; Ninković J; Prokopowicz ZM; Mancuso CJ; Marin A; Andrianov AK; Dowling DJ; Levy O
Biomaterials; 2014 Oct; 35(31):8876-8886. PubMed ID: 25023392
[TBL] [Abstract][Full Text] [Related]
17. Baccatin III, a synthetic precursor of taxol, enhances MHC-restricted antigen presentation in dendritic cells.
Lee YH; Lee YR; Kim KH; Im SA; Song S; Lee MK; Kim Y; Hong JT; Kim K; Lee CK
Int Immunopharmacol; 2011 Aug; 11(8):985-91. PubMed ID: 21354357
[TBL] [Abstract][Full Text] [Related]
18. Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG-PLA Conjugate for Tuning Immunity.
Coumes F; Huang CY; Huang CH; Coudane J; Domurado D; Li S; Darcos V; Huang MH
Biomacromolecules; 2015 Nov; 16(11):3666-73. PubMed ID: 26473322
[TBL] [Abstract][Full Text] [Related]
19. Mannosylated dextran nanoparticles: a pH-sensitive system engineered for immunomodulation through mannose targeting.
Cui L; Cohen JA; Broaders KE; Beaudette TT; Fréchet JM
Bioconjug Chem; 2011 May; 22(5):949-57. PubMed ID: 21476603
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of immunomodulators in biodegradable nanoparticles improves therapeutic efficacy of cancer vaccines.
Da Silva CG; Camps MGM; Li TMWY; Chan AB; Ossendorp F; Cruz LJ
Biomaterials; 2019 Nov; 220():119417. PubMed ID: 31419588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
